Clinical Site
Sofia 1784
4 studies enrolling now · 17 studies all time
What they study most
Arthritis, Psoriatic, Bipolar Depression, Bipolar Disorder, Manic, Generalized Anxiety Disorder, Hidradenitis Suppurativa, Major Depressive Disorder, Schizophrenia
Studies at this site
- Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response — Recruiting now
- Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
- Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
- Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania — Completed
- Study of Lumateperone in the Treatment of Patients With Bipolar Mania — Completed
- Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug — Running, not enrolling
- A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa — Enrolling by invitation
- Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Completed
- A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Completed
- An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
- Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
- Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder — Completed
- Lumateperone for the Prevention of Relapse in Patients With Schizophrenia — Completed
- Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis — Completed
- Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa — Completed
- Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression — Completed
- Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally — Completed